Eastpharma Ltd GDR (LSE:63PE) - Share price - Overview


Stock Report

Eastpharma Ltd 63PE

Last Price
$-

Day Change
-|-%

As of -
- | USD
Minimum 15 Minutes Delay.

Last Close-
Day Range-
Mkt Cap-
52-Wk Range-
Yield %-
ISINUS27778Q1058
Volume-
P/E-
P/S-
P/CF-

Share Price

Total Returns -

 Chg (%)  
More ...
Eastpharma Ltd- 
FTSE 100 TR GBP2.00
 
Financials
201620172018
More ...
Income Statement
Turnover224.92220.43233.92
Operating Profit39.0842.6261.51
Net Profit18.4727.8234.16
Reported EPS0.230.350.43
Balance Sheet
Current Assets137.57176.47195.19
Non Current Assets212.71218.15173.60
Total Assets350.28394.62368.78
Current Liabilities73.85114.97113.82
Total Liabilities---
Total Equity202.70217.90190.31
Cash Flow
Operating Cash Flow55.7027.1040.60
Net Change in Cash-5.3511.441.35

Company Profile

Eastpharma Ltd is a pharmaceutical company engaged in manufacturing and marketing of branded and in-licensed generic pharmaceuticals in Turkey and other regional markets. It has a wide range of product portfolio and a country-wide organized sales force.

Sector

Drug Manufacturers - Major

Index

Next Event 16/05/2019

Annual General Meeting
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE25.09
Op Mrgn0.26
EPS Grwth0.36
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Executive DirectorJohn Coombe-Tennant BA
Executive DirectorPeter Baird CFA,BA,MA,MBA
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.